Page last updated: 2024-08-23

tetradecanoylphorbol acetate and cgp 53716

tetradecanoylphorbol acetate has been researched along with cgp 53716 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchdunger, E; Lydon, NB; Mett, H; Meyer, T; Müller, M; Regenass, U; Zimmermann, J1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and cgp 53716

ArticleYear
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Mar-28, Volume: 92, Issue:7

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Line, Transformed; Epidermal Growth Factor; Female; Fibroblast Growth Factor 2; Humans; Kinetics; Mice; Mice, Inbred BALB C; Mice, Nude; Oncogene Proteins v-sis; Oncogenes; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Retroviridae Proteins, Oncogenic; Signal Transduction; Tetradecanoylphorbol Acetate; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured

1995